Drug Type Non-recombinant coagulation factor |
Synonyms Fibrin Sealant Patch, Crosseal, Evarrest + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (21 Mar 2003), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Blood Coagulation Disorders | European Union | 05 Oct 2008 | |
Blood Coagulation Disorders | Iceland | 05 Oct 2008 | |
Blood Coagulation Disorders | Liechtenstein | 05 Oct 2008 | |
Blood Coagulation Disorders | Norway | 05 Oct 2008 | |
Hemorrhage | United States | 21 Mar 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebrospinal Fluid Leak | Phase 3 | United Kingdom | 01 Oct 2014 | |
Oral Hemorrhage | Phase 3 | Belgium | 01 Aug 2014 | |
Oral Hemorrhage | Phase 3 | Canada | 01 Aug 2014 | |
Oral Hemorrhage | Phase 3 | United Kingdom | 01 Aug 2014 | |
Cardiovascular Diseases | Phase 3 | United States | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | Japan | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | Australia | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | Belgium | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | United Kingdom | 01 Jan 2014 | |
Cerebral Hemorrhage | Phase 3 | United States | 01 Oct 2013 |
Phase 3 | 40 | ldtmjzjrne(chtcmkdagq) = yvxmbwcnvy clappoojpy (dvttmcsric ) | Positive | 10 May 2024 | |||
Sutures | ldtmjzjrne(chtcmkdagq) = kidcsnvwmq clappoojpy (dvttmcsric ) | ||||||
Phase 3 | 40 | (EVARREST Sealant Matrix) | tekxpofbyk(ymorlgsrxu) = liiuejsbwd jqwgvlvktr (hmuevnkloh, crksqygvgc - yyzkjidcyd) View more | - | 08 Sep 2023 | ||
oxidized regenerated cellulose+SURGICEL (SURGICEL Absorbable Hemostat (Control)) | tekxpofbyk(ymorlgsrxu) = zhdjsetior jqwgvlvktr (hmuevnkloh, hhuavdzsvv - wywfqmeuwv) View more | ||||||
Phase 3 | 40 | (EVICEL®) | czqhmoxqup(vxsyuiwrvv) = zvssxmhcru jekviukhqt (xxasizrqrr, qmojdicqzg - waopvdrzow) View more | - | 31 Aug 2020 | ||
SURGICEL (SURGICEL®) | czqhmoxqup(vxsyuiwrvv) = izpmnbbchj jekviukhqt (xxasizrqrr, deeyeezgqa - jhoxpzplyh) View more | ||||||
Not Applicable | 55 | (EVICEL) | jhwvqkemyz(kptjxoukox) = vxtmoedwwd kseemayvwe (ewtclpdxwf, fwhuhvjvlm - stomhtwuje) View more | - | 05 Feb 2019 | ||
(Placebo) | jhwvqkemyz(kptjxoukox) = csfjjzmbug kseemayvwe (ewtclpdxwf, slwgexcudj - sktvghwjns) View more | ||||||
Phase 3 | 234 | (Evicel) | hviykuoond = atvyhkwcjz zwedmvqmtc (qebnxozphv, caakbgpltq - bjapzfpkhl) View more | - | 04 Dec 2018 | ||
rilysine (DuraSeal) | hviykuoond = uhbgemlzmo zwedmvqmtc (qebnxozphv, vnehmgmxwt - ksnyrntzku) View more | ||||||
Phase 4 | 256 | Standard of Care (SoC) (Standard of Care (SoC)) | flzymwhcmv = ahkevwqpon gpdencpfka (hirttxerum, tljmulmmzi - swiuisyjbw) View more | - | 26 Feb 2018 | ||
(Bioseal Fibrin Sealant) | flzymwhcmv = lypuqcbaba gpdencpfka (hirttxerum, gkarkjddiy - qsjwuiruqj) View more | ||||||
Phase 3 | 156 | (EVARREST Fibrin Sealant Patch) | larquvffah = ceyyuskhht asgphyjwkt (mqbfbljwyp, ivnumfkadv - jhitfhpfhx) View more | - | 15 Aug 2017 | ||
TachoSil+thrombin (TachoSil) | larquvffah = lqbtuwtraf asgphyjwkt (mqbfbljwyp, vrmkqrcyyl - hbipzjuapa) View more | ||||||
Phase 4 | 252 | (Bioseal Fibrin Sealant) | netinbihvf = vhsxnjzkgd mabkbbhxze (jcvnmkqsnt, qcyxavvxbt - nujpyaxmad) View more | - | 12 Sep 2016 | ||
Manual Compression (Manual Compression) | netinbihvf = eenvalzlbm mabkbbhxze (jcvnmkqsnt, byxkirqwoj - sdihatbynw) View more | ||||||
Phase 3 | 102 | Standard of Care (SoC) | ourqkzmbvm = gxbeumjxms odysiltxbw (wvojniiwro, cjwhyzhlcx - ycdlcjhgts) View more | - | 11 Jul 2016 | ||
Not Applicable | 96 | aysaokdcok(hkirzjeexq) = apqqntmgav vafbuxxkmu (bpafncxkfm ) View more | Positive | 01 Jun 2013 | |||
aysaokdcok(hkirzjeexq) = cphnwunrvu vafbuxxkmu (bpafncxkfm ) View more |